Ligand Pharmaceuticals, Inc. (LGND)
207.64
+4.72
(+2.33%)
USD |
NASDAQ |
Mar 16, 16:00
207.64
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Total Assets (Quarterly) : 1.561B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 949.87M |
| ADMA Biologics, Inc. | 633.35M |
| Merck & Co., Inc. | 136.87B |
| Globus Medical, Inc. | 5.303B |
| Establishment Labs Holdings, Inc. | 357.17M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 543.42M |
| Shareholders Equity (Quarterly) | 1.017B |
| Debt to Equity Ratio | 0.4439 |
| Current Ratio | 22.23 |
| Net Debt Paydown Yield | -2.38% |